Results 181 to 190 of about 181,509 (297)
Considerations for drug trials in hypertrophic cardiomyopathy
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant +17 more
wiley +1 more source
Sternal Complications After Clamshell Surgery for (Heart-)Lung Transplantation-A Systematic Literature Review. [PDF]
Klei DS +4 more
europepmc +1 more source
This graphic abstract depicts the convergence of artificial intelligence, genetic technologies, bioengineering, and rehabilitation as the core pillars of next‐generation surgery. These domains collectively enhance preoperative planning, intraoperative precision, tissue reconstruction, and postoperative recovery, driving a paradigm shift toward ...
Dengxiong Li +17 more
wiley +1 more source
En Bloc Heart-Lung Transplantation: Past and Present. A Systematic Review. [PDF]
El-Andari R +6 more
europepmc +1 more source
The experiences of adult heart, lung, and heart-lung transplantation recipients: A systematic review of qualitative research evidence. [PDF]
Stubber C, Kirkman M.
europepmc +1 more source
Bioactive Magnesium Silicate Activating Myocardial Energy Metabolism For Infarcted Myocardium Repair
ABSTRACT The heart is a highly energy‐dependent organ, developing bioenergy‐activating biomaterials to activate myocardial adenosine triphosphate (ATP) production and restore dysregulated energy homeostasis is a promising solution for its functional recovery.
Zhibin Liao +11 more
wiley +1 more source
Four decades of heart-lung transplantation: Milestones and outcomes in advanced cardiorespiratory failure. [PDF]
Rosenthal LL +10 more
europepmc +1 more source
A New Vista of Opportunity in Diabetes Management: Natural Product‐Based β‐cell Preservation
Preserving functional β‐cells via natural products offers promising strategy for diabetes treatment. ABSTRACT A defining characteristic of diabetes is β‐cell failure, in which β‐cells cannot modulate insulin secretion to compensate for escalating insulin resistance, pushing forward disease development.
Yi‐San Lee +4 more
wiley +1 more source

